Apotex Product Recall (2015-04-10) Apr 10, 2015 · Published by Health Canada · Official notice
Share
Alert type : Drug Recall
Category : Drugs
Issue : Product Safety
Audience : General Public, Healthcare Professionals, Hospitals
Department : Health Canada
Hazard classification : Type II and III
Lot or serial number Brand name Companies Dosage form DIN, NPN, DIN-HIM Strength KL7884 D. APO-Verap SR 240 mg (Type-III) Recalling Firm Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA Marketing Authorization Holder Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA Tablet (Extended-Release) DIN 02246895 Verapamil hydrochloride 240 mg KW3889 B. APO-Pregabalin 50 mg (Type-II) Recalling Firm Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA Marketing Authorization Holder Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA Capsules DIN 02394243 Pregabaline 50 mg KN9046 C. APO-Pregabalin 75 mg (Type-II) Recalling Firm Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA Marketing Authorization Holder Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA Capsules DIN 02394251 Pregabaline 75 mg KV5559, KV5562, KW0448, KV5560, KV5561 A. APO-Candesartan 16 mg (Type-II) Recalling Firm Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA Marketing Authorization Holder Apotex Inc. 150 Signet Drive Toronto M9L 1T9 Ontario CANADA Tablets DIN 02365367 Candesartan cilexetil 16 mg
Recalled Products
A. APO-Candesartan 16 mg (Type-II)
B. APO-Pregabalin 50 mg (Type-II)
C. APO-Pregabalin 75 mg (Type-II)
D. APO-Verap SR 240 mg (Type-III)
Out of specification results during stability testing for CAD-II impurity (APO-Candesartan), unidentified impurity (APO-Pregabalin) and dissolution test (APO-Verap SR)
Wholesaler and Distributor